Scarica l'app Stockscreener
0.827
3.56%
-0.0305
Dopo l'orario di chiusura:
.83
0.003
+0.36%
Prelude Therapeutics Inc Borsa (PRLD) Ultime notizie
Published on: 2025-08-11 08:04:14 - Newser
Tick level data insight on Prelude Therapeutics Incorporated volatilityPattern Recognition Based Market Move Prediction - Newser
Using data filters to optimize entry into Prelude Therapeutics IncorporatedConsistent Gain Plan with AI Support - Newser
How to build a dashboard for Prelude Therapeutics Incorporated stockPrice Spike Prediction for Active Traders - Newser
Prelude Therapeutics Incorporated’s volatility index tracking explainedMulti-Year Signal Summary and Entry Timing - Newser
Is it time to cut losses on Prelude Therapeutics IncorporatedMinimal Risk Growth Investment Opportunity Analysis - Newser
Will Prelude Therapeutics Incorporated bounce back from current supportCapital Growth Summary Over Five Years - Newser
Can machine learning forecast Prelude Therapeutics Incorporated recoveryLong Term Stock Planner with Safety Checks - Newser
Why Prelude Therapeutics Incorporated stock attracts strong analyst attentionTen-Year Sector Performance and Summary Analysis - Newser
What makes Prelude Therapeutics Incorporated stock price move sharplyFree Real Time Trade Opportunity Alerts - Newser
Is Prelude Therapeutics Incorporated reversing from oversold territoryFree Weekly Growth Stock Entry Point Alerts - Newser
Will Prelude Therapeutics Incorporated stock go up soonFree Weekly Hot Picks With Buy Confidence - Newser
Prelude Therapeutics (PRLD) to Release Quarterly Earnings on Monday - Defense World
Published on: 2025-08-08 17:57:29 - Newser
Prelude Therapeutics Inc expected to post a loss of 44 cents a shareEarnings Preview - TradingView
Has Prelude Therapeutics Incorporated found a price floorLong-Term Investment Strategy Summary Guide - Newser
Using fundamentals and technicals on Prelude Therapeutics IncorporatedTrend Following Ideas with Volume Confirmation - Newser
What recovery options are there for Prelude Therapeutics IncorporatedFree Swing Trade Entry With Volume Triggers - Newser
Using data models to predict Prelude Therapeutics Incorporated stock movementFree ROI Boosting Trade Opportunity Calendar - Newser
Is Prelude Therapeutics Incorporated stock entering bullish territoryPre-Market Stock Movement Summary and Review - Newser
Published on: 2025-08-04 06:59:59 - Newser
What institutional investors are buying Prelude Therapeutics Incorporated stockFree Predictions - Jammu Links News
Published on: 2025-08-04 00:18:44 - Newser
What analysts say about Prelude Therapeutics Incorporated stockGet ahead with breakthrough trading ideas - Jammu Links News
How volatile is Prelude Therapeutics Incorporated stock compared to the marketCapitalize on momentum stocks early - Jammu Links News
What are the technical indicators suggesting about Prelude Therapeutics IncorporatedMarket-leading growth rates - Jammu Links News
Does Prelude Therapeutics Incorporated qualify in momentum factor screeningBuy Strategy Tracker with Growth Indicators - Newser
Prelude Therapeutics Incorporated stock trendline breakdownFree Sector Based Breakout Stock Forecast - Newser
When is Prelude Therapeutics Incorporated stock expected to show significant growthNavigate market shifts with confidence - Jammu Links News
Should I hold or sell Prelude Therapeutics Incorporated stock in 2025Accelerated earnings growth - Jammu Links News
What are analysts’ price targets for Prelude Therapeutics Incorporated in the next 12 monthsAchieve rapid capital gains with smart investing - Jammu Links News
What is the dividend policy of Prelude Therapeutics Incorporated stockTriple-digit return opportunities - Jammu Links News
What are Prelude Therapeutics Incorporated company’s key revenue driversGet alerts on high-potential market moves - Jammu Links News
How does Prelude Therapeutics Incorporated compare to its industry peersExplosive market performance - Jammu Links News
Is it the right time to buy Prelude Therapeutics Incorporated stockUnmatched profit potential - Jammu Links News
1.02%
3.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):